Weekend Unlimited Industries Inc. (OTC:WKULF)(CSE:POT) is a lifestyle-based medicinal cannabis and CBD wellness company selling premium brand products in the U.S. Weekend Unlimited’s products are produced from certified organic hemp Cannabidiol (CBD) and are available in the US online and at a growing number of Oklahoma state retailers.
The global CBD market is forecasted to grow from $1,453.81 million in 2018 to $17,345.80 million by 2026, a CAGR of 36.3% between 2019 and 2026. Legal cannabis spending was worth $14.3 billion in 2017 and is forecasted to grow to $63.5 billion by 2024, an annual increase of 21.1%:
The CBD sector therefore finds itself riding the wave of booming eCommerce sales and skyrocketing demand for CBD products. f (OTC:WKULF)(CSE:POT) is attempting to capitalize on this market, in part, because:
Consumers are becoming more environmentally aware than ever and interested in buying organic, non-GMO products. Moreover, they are increasingly health-conscious, and recognize CBD products for their astounding immune-boosting properties, high protein content, improvement of cardiovascular function, pain-relief properties, and much more.
By creating a range of high-quality organic CBD products, sold both via retail outlets and online, OTC:WKULF/CSE:POT is addressing the needs of its consumers.
OTC:WKULF/CSE:POT’s WKND! Wellness brand is spearheaded by a range of original CBD products made with the high-quality ingredients, sourced exclusively from America’s best non-GMO hemp plantations. They are pesticide-free, chemical-free, and grown in accordance with advanced organic farming practices. The WKND! Wellness product line includes:
WKND! Wellness Full-Spectrum CBD Oil Tinctures
Available in Natural (unflavored) and Mint flavors, these tinctures provide 1,000 mg CBD in a 1-ounce bottle. They include other beneficial phytocannabinoids designed to relieve stress, recover from exercise, create a sense of well-being, and improved sleeping.
WKND! Wellness Extra Strength Full-Spectrum Softgels
Nano-emulsified CBD oil softgels formulated to ensure a consistent 25 mg dose of full-spectrum CBD in every capsule.
WKND! Wellness Full-Spectrum CBD Cooling Gel
This organic CBD cooling gel includes the natural botanicals menthol and camphor for a fast-acting cooling sensation plus the added relaxing benefits of CBD. Designed specifically for recovery from exercise and overexertion.
WKND! Wellness Full-Spectrum CBD Vanilla/Coconut Natural Body Butter
A full-spectrum CBD body butter made from all-natural, plant-based ingredients to calm and moisturize dry, itchy skin. A premium blend of natural oils, WKND! Wellness CBD body butter delivers moisture and all the benefits of CBD to skin.
The CBD sector moves fast - but OTC:WKULF/CSE:POT has been moving faster:
The entry into Oklahoma is the key to understanding OTC:WKULF/CSE:POT’s strategy in the CBD market.
On April 23d, the company announced it would expand its product line to include CBD Tincture and Elderberry Gummies to cater to the explosive growth in demand.
OTC:WKULF/CSE:POT has recently generated material sales in these immensely dynamic CBD niches, and is continuously refining its products to fit customer needs. What’s more, One recent rounds of financing in February and March for CAD $1.1 million have given OTC:WKULF/CSE:POT the needed financial ammunition to propel its expansion further.
On June 15th the company announced unaudited Q3 2020 financial results, showing that:
WKND! Wellness product sales increased 487% MOM in June to date
Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, including, without limitation, statements regarding future financial position, business strategy, use of proceeds, corporate vision, proposed acquisitions, partnerships, joint-ventures and strategic alliances and co-operations, budgets, cost and plans and objectives of or involving the Company. Such forward-looking information reflects management's current beliefs and is based on information currently available to management. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "predicts", "intends", "targets", "aims", "anticipates" or "believes" or variations (including negative variations) of such words and phrases or may be identified by statements to the effect that certain actions "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. A number of known and unknown risks, uncertainties and other factors may cause the actual results or performance to materially differ from any future results or performance expressed or implied by the forward-looking information. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company including, but not limited to, the impact of general economic conditions, industry conditions and dependence upon regulatory approvals. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company does not assume any obligation to update or revise its forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by securities laws.
Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below.
We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before, during or after our dissemination of the Information, and make profits therefrom. EMC does not verify or endorse any medical claims for any of its client companies.
Must Read OTC Markets/SEC policy on stock promotion and investor protection
EMC has been paid 15,000 dollars by Investing Channel and 5000 dollars by Weekend unlimited for a landing page and for various marketing services including this report. EMC does not independently verify any of the content linked-to from this editorial. https://www.emergingmarketsllc.com/disclaimer/